Munich Re: I'm Back In (Rating Upgrade)

Munich Re is upgraded to 'BUY' with a price target of €480/share, as valuation has become attractive below €460/share. MURGY offers a 5.23% well-covered dividend, AA credit rating, low debt, and robust fundamentals, with a 20-year average valuation of 12-13x P/E. Current entry at 9.2–9.5x P/E provides a significant margin of safety and double-digit upside, even at modest growth rates.

Seeking Alpha • Jun 15, 2026

Should Value Investors Buy Mnchener RckversicherungsGesellschaft (MURGY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Jun 1, 2026

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Q1 2026 Earnings Call Transcript

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 14, 2026

3 Reasons Growth Investors Will Love Mnchener RckversicherungsGesellschaft (MURGY)

Mnchener RckversicherungsGesellschaft (MURGY) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research • May 13, 2026

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Q1 2026 Earnings Call Prepared Remarks Transcript

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Q1 2026 Earnings Call Prepared Remarks Transcript

Seeking Alpha • May 12, 2026

MURGY vs. OSCR: Which Stock Is the Better Value Option?

Investors looking for stocks in the Insurance - Multi line sector might want to consider either M?nchener R?ckversicherungs-Gesellschaft (MURGY) or Oscar Health, Inc. (OSCR). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • May 8, 2026

Mnchener RckversicherungsGesellschaft (MURGY) Upgraded to Strong Buy: Here's Why

Mnchener RckversicherungsGesellschaft (MURGY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Apr 30, 2026

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Shareholder/Analyst Call Prepared Remarks Transcript

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Shareholder/Analyst Call Prepared Remarks Transcript

Seeking Alpha • Apr 29, 2026

U.S. Pet Insurance Market Growth Slows In 2025, But Still Robust

The US pet insurance market once again expanded by more than 10% in 2025, a feat that it has achieved every year since at least 2018. The pet insurance industry's net loss ratio, which has remained almost flat since 2017, improved modestly to 74.2% in 2025 from 76.1% in the prior year.

Seeking Alpha • Apr 9, 2026

8 Attractive Dividend Stocks For Global Diversification: One Yields More Than 6%

I highlight a diversified set of global dividend stocks—Nestlé, Banco Santander, Münchener Rückversicherungs-Gesellschaft, Canadian Natural Resources, Allianz, Petrobras, British American Tobacco, and Bank of Nova Scotia—for income and portfolio risk reduction. Petrobras stands out for its exceptionally low P/E of 7.10, high dividend yield of 6.67%, and strong profitability but carries elevated currency and political risks. Nestlé offers low volatility and defensive characteristics, though its dividend and earnings growth rates are modest, making it a stabilizing rather than high-growth portfolio addition.

Seeking Alpha • Mar 12, 2026